Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are over 18 years old
- Your Body Mass Index (BMI, a measure of body weight relative to height) is above 30, which is generally considered obese
- You have not yet had a heart attack, stroke, or other cardiovascular (heart and blood vessel) event — meaning you are being seen as a preventative measure
- You are able to communicate clearly and follow the steps required by the study
- You are willing to take part and have given your formal agreement (informed consent)
Who may not be able to join:
- People who are already taking part in another study run by the same research teams involved in this trial
- People whose blood sugar control measure (a test called glycated hemoglobin, or HbA1c) is above a certain level, suggesting poorly controlled blood sugar (confirm with trial site)
- People whose obesity is caused by a hormonal (endocrine) condition or by a medication they are taking
- People with a specific inherited cholesterol condition called Familial Hypercholesterolemia, identified by a particular scoring system (confirm with trial site)
- People whose high cholesterol is caused by another medical condition or by a medication they are taking
- People living with an ongoing inflammatory condition or cancer
- People currently taking a type of medication called GLP-1 analogues (commonly used for diabetes or weight management)
- People who are pregnant or breastfeeding
- People with any medical or surgical condition that would make it difficult to follow the study's requirements reliably
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maria Letizia Petroni, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: +0512143281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
cycle threshold miRNAs; Presence/absence of the loss-of-function HMGA1 allelic variant (rs146052672); NGS sequencing of the genes: MC4R, LEP, LEPR, POMC, PCSK1, ADRA2, AGPAT2, HIF1A, HMGA2, HMGB1, INSR, PEPCK, GLUT/SGLT glucose transporters.; Insulinemia (µU/mL); C-peptide (nmol/L); thyrotropin (nmol/L); HMGA1 protein assay
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.